Patient-centric approaches and personalized nanomedicine in skin cancer

Area of Science:

• Dermatologic Oncology
• Nanomedicine
• Personalized Medicine

Background:

• Skin cancer, including melanoma and non-melanoma types, remains a global health concern.
• Traditional treatments face challenges like drug resistance, recurrence, and variable patient responses.
• There is a need for innovative strategies to enhance skin cancer treatment efficacy and patient care.

Purpose of the Study:

• To review the integration of personalized nanomedicine and patient-centric care models for skin cancer treatment.
• To explore how these combined approaches can overcome limitations of conventional therapies.
• To highlight recent advancements, clinical applications, and future directions in this field.

Main Methods:

• Review of current literature on personalized nanomedicine (liposomes, dendrimers, gold nanoparticles) and patient-centric care models.
• Analysis of strategies including molecular profiling, biomarker-guided therapy, shared decision-making, and mobile health technologies.
• Examination of how these approaches enable precise drug delivery and tailored treatment plans.

Main Results:

• Personalized nanomedicine facilitates targeted, effective, and less toxic drug delivery.
• Patient-centric care enhances treatment adherence and patient satisfaction through shared decision-making and feedback.
• The combination allows for treatments tailored to patients' biological and psychosocial characteristics, improving therapeutic results.

Conclusions:

• Integrating personalized nanomedicine and patient-centric care holds significant potential to revolutionize skin cancer treatment.
• This synergistic approach promises improved efficacy, reduced toxicity, and a more holistic patient experience.
• Further research and clinical translation are crucial for realizing the full impact of these advanced therapeutic strategies.